Literature DB >> 19144336

Progression of atherosclerosis in the Apo E-/- model: 12-month exposure to cigarette mainstream smoke combined with high-cholesterol/fat diet.

K von Holt1, S Lebrun, W Stinn, L Conroy, T Wallerath, R Schleef.   

Abstract

This study was performed to gain information about the influence of two cardiovascular risk factors, cigarette mainstream smoke (MS) and high-cholesterol/fat diet, on the progression of atherosclerosis in apolipoprotein E-deficient (Apo E-/-) mice. Eight to 12-week-old mice were whole-body exposed for up to 12 months (6h/day, 5 days/week) to diluted cigarette mainstream smoke at total particulate matter (TPM) concentrations of 100 or 200mg/m(3), or to filtered fresh air (sham) in combination with a normal chow diet or a high-cholesterol/fat diet. Cholesterol in the aortic arch was elevated in the high-cholesterol/fat diet groups exposed to 200 mg TPM/m(3) compared to sham at all time points. In the brachiocephalic artery (BA), absolute plaque size and fraction area of plaques was elevated over the 12-month time course in mice exposed to 200 mg TPM/m(3) compared to sham (both diets). Exposure to 100 and 200 mg TPM/m(3) altered the number of elastin-rich layers in the BA in mice fed a high-cholesterol/fat diet, indicating changes in plaque morphology at 6 and 9 months. This study shows for the first time the influence of two different risk factors, MS and high-cholesterol/fat diet, both alone and in combination over a period of 12 months, on the progression of atherosclerosis in Apo E-/- mice. Data suggest that long-term exposure to cigarette mainstream smoke accelerates the development of atherosclerosis in Apo E-/- mice, particularly in combination with a high-cholesterol/fat diet.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19144336     DOI: 10.1016/j.atherosclerosis.2008.11.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  Quit smoking to outsmart atherogenesis: Molecular mechanisms underlying clinical evidence.

Authors:  Jessica Gambardella; Celestino Sardu; Cosimo Sacra; Carmine Del Giudice; Gaetano Santulli
Journal:  Atherosclerosis       Date:  2016-12-16       Impact factor: 5.162

2.  Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD.

Authors:  Gnanapragasam Arunachalam; Isaac K Sundar; Jae-Woong Hwang; Hongwei Yao; Irfan Rahman
Journal:  J Inflamm (Lond)       Date:  2010-07-22       Impact factor: 4.981

3.  Developmental cigarette smoke exposure II: Kidney proteome profile alterations in 6 month old adult offspring.

Authors:  Rachel E Neal; Rekha Jagadapillai; Jing Chen; Cynthia L Webb; Kendall Stocke; Cailtin Gambrell; Robert M Greene; M Michele Pisano
Journal:  Reprod Toxicol       Date:  2016-05-18       Impact factor: 3.143

4.  Structural and functional remodeling of the female Apoe-/- mouse aorta due to chronic cigarette smoke exposure.

Authors:  Yasmeen M Farra; Jacqueline Matz; Bhama Ramkhelawon; Jessica M Oakes; Chiara Bellini
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-04-09       Impact factor: 5.125

5.  Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains.

Authors:  Maciej Cabanski; Brett Fields; Stephanie Boue; Natalia Boukharov; Hector DeLeon; Natalie Dror; Marcel Geertz; Emmanuel Guedj; Anita Iskandar; Ulrike Kogel; Celine Merg; Michael J Peck; Carine Poussin; Walter K Schlage; Marja Talikka; Nikolai V Ivanov; Julia Hoeng; Manuel C Peitsch
Journal:  Inflamm Res       Date:  2015-05-12       Impact factor: 4.575

6.  Lentinus edodes promotes fat removal in hypercholesterolemic mice.

Authors:  Hyun Yang; Inho Hwang; Sun Kim; Eui-Ju Hong; Eui-Bae Jeung
Journal:  Exp Ther Med       Date:  2013-10-08       Impact factor: 2.447

7.  A vascular biology network model focused on inflammatory processes to investigate atherogenesis and plaque instability.

Authors:  Héctor De León; Stéphanie Boué; Walter K Schlage; Natalia Boukharov; Jurjen W Westra; Stephan Gebel; Aaron VanHooser; Marja Talikka; R Brett Fields; Emilija Veljkovic; Michael J Peck; Carole Mathis; Vy Hoang; Carine Poussin; Renee Deehan; Katrin Stolle; Julia Hoeng; Manuel C Peitsch
Journal:  J Transl Med       Date:  2014-06-26       Impact factor: 5.531

8.  The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.

Authors:  P Padmini S J Khedoe; Man C Wong; Gerry T M Wagenaar; Jaap J Plomp; Miranda van Eck; Louis M Havekes; Patrick C N Rensen; Pieter S Hiemstra; Jimmy F P Berbée
Journal:  PLoS One       Date:  2013-11-26       Impact factor: 3.240

Review 9.  The Apoe(-/-) mouse model: a suitable model to study cardiovascular and respiratory diseases in the context of cigarette smoke exposure and harm reduction.

Authors:  Giuseppe Lo Sasso; Walter K Schlage; Stéphanie Boué; Emilija Veljkovic; Manuel C Peitsch; Julia Hoeng
Journal:  J Transl Med       Date:  2016-05-20       Impact factor: 5.531

10.  An 8-Month Systems Toxicology Inhalation/Cessation Study in Apoe-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of a Candidate Modified Risk Tobacco Product, THS 2.2, Compared With Conventional Cigarettes.

Authors:  Blaine Phillips; Emilija Veljkovic; Stéphanie Boué; Walter K Schlage; Gregory Vuillaume; Florian Martin; Bjoern Titz; Patrice Leroy; Ansgar Buettner; Ashraf Elamin; Alberto Oviedo; Maciej Cabanski; Héctor De León; Emmanuel Guedj; Thomas Schneider; Marja Talikka; Nikolai V Ivanov; Patrick Vanscheeuwijck; Manuel C Peitsch; Julia Hoeng
Journal:  Toxicol Sci       Date:  2015-11-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.